4th Annual Genome Editing USA Congress

by BiopharmaTrend 

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   959    Comments 0

The congress will showcase the latest technologies, drugs and in vivo therapeutic solutions that are being produced by pioneers in the genome editing field. The congress will feature over 30 presentations in a comprehensive conference programme designed to provide an increased knowledge of current trends influencing gene editing research. Key speakers include Directors from Novartis, Pfizer, Harvard, MIT and more.

Over 350 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

3 outstanding programmes bringing together Europe’s key genomics experts in Next Generation Sequencing, Single Cell Analysis, Genome Editing.

Over 80 case studies, solution & technology presentations and 2 interactive workshops over the 2 days.

07 April 2019 – Day One

  • Genome Editing Technologies & Techniques
  • Drug Discovery & Development Applications in In Vivo Therapeutics

08 April 2019 – Day Two

  • Drug Discovery & Development – Target Identification and Validation
  • Non-Human Models in Diagnostics & Therapeutics

View Agenda: http://bit.ly/2QQzSYZ  

Date: 07 - 08 April 2020

Location: Boston, USA

Share this:              


There are no comments yet. You can be the first.

Leave a Reply

Your email address will not be published. Required fields are marked *